Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Challenges for Management of Immune Thrombocytopenia During Covid-19 Pandemic Publisher Pubmed



Sahu KK1 ; Siddiqui AD1 ; Rezaei N2, 3, 4 ; Cerny J5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Division of Hematology and Oncology, Department of Medicine, Saint Vincent Hospital, Worcester, MA, United States
  2. 2. Division of Immunology, Research Center for Immunodeficiencies, Children's Medical Center, University of Medical Sciences, Tehran, Iran
  3. 3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Division of Immunology, Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  5. 5. Division of Hematology and Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA, United States

Source: Journal of Medical Virology Published:2020


Abstract

[No abstract available]
Other Related Docs
10. Intensive Care Admission Rate Due to Covid-2109, International Journal of Pharmaceutical Research (2020)
18. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
23. Fatty Liver in Covid-19: A Risk Factor or a Common Receptor?, Archives of Iranian Medicine (2021)
24. Bibliometric Analysis of Global Scientific Research on Coronavirus (Covid-19), Medical Journal of the Islamic Republic of Iran (2020)
40. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
41. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)